Tuesday, August 21, 2018 10:37:08 AM
Today's shareholder update:
posted on OTC disclosures:
To Our Shareholders:
I am very pleased to be able to communicate with our loyal shareholders directly and to give you an update on our progress to date as well as the direction the Company is going.
Elev8 Brands, Inc. is a holding company focused on the commercial development and marketing of hemp and CBD-based products including hemp coffee, hemp tea, hemp cold brew, hemp extract, CBD tinctures, CBD lotion, and CBD salve which target the health and wellness markets. The Company is founded on the basis of creating high-quality, sustainable, products for health-conscious consumers.
Some of you may have noticed an increase in the Company's reported public float. In the past, I've always reported the float as the shares of common stock held in street name. However, during the course of the Company's audit, I was informed that I need to also include all shares that have been held by non-affiliates for over one year in the reported public float. Therefore, the number reported has increased.
Elev8 Hemp is pleased to announce that it has officially launched its decaffeinated hemp coffee on Amazon Prime. At every promotion that we have held, inevitably several people request a decaffeinated version of our house blend and we are very excited to bring this to market. In addition, Elev8 Hemp has plans to bring some seasonal hemp coffees to market this fall.
The Company’s newest acquisition, L&P Cold Brew, is currently in negotiations to secure warehouse space. Along with this new space L&P Cold Brew is working on an agreement for new manufacturing equipment to allow the Company to produce its cold brew products in house. This new lease should be finalized within the next 45 days.
L&P Cold Brew is looking to obtain part of the global ready to drink market share which, according to a report by Grand View Research, Inc. the global ready to drink tea and coffee market size is expected to reach 116.13 billion USD by 2024. US Sales alone in 2017 were over $38.1 million which is up over 460% from 2015
In closing, we have had another exceptional second quarter with revenue increase of over 17%. We are very excited about what we have accomplished thus far and are looking forward to an amazing second half of the year.
To follow the Company’s latest developments visit us on https://www.instagram.com/elev8hemp, on https://www.facebook.com/elev8hemp, and on https://twitter.com/elev8hemp.
Sincerely Yours,
Ryan Medico
Chief Executive Officer
posted on OTC disclosures:
To Our Shareholders:
I am very pleased to be able to communicate with our loyal shareholders directly and to give you an update on our progress to date as well as the direction the Company is going.
Elev8 Brands, Inc. is a holding company focused on the commercial development and marketing of hemp and CBD-based products including hemp coffee, hemp tea, hemp cold brew, hemp extract, CBD tinctures, CBD lotion, and CBD salve which target the health and wellness markets. The Company is founded on the basis of creating high-quality, sustainable, products for health-conscious consumers.
Some of you may have noticed an increase in the Company's reported public float. In the past, I've always reported the float as the shares of common stock held in street name. However, during the course of the Company's audit, I was informed that I need to also include all shares that have been held by non-affiliates for over one year in the reported public float. Therefore, the number reported has increased.
Elev8 Hemp is pleased to announce that it has officially launched its decaffeinated hemp coffee on Amazon Prime. At every promotion that we have held, inevitably several people request a decaffeinated version of our house blend and we are very excited to bring this to market. In addition, Elev8 Hemp has plans to bring some seasonal hemp coffees to market this fall.
The Company’s newest acquisition, L&P Cold Brew, is currently in negotiations to secure warehouse space. Along with this new space L&P Cold Brew is working on an agreement for new manufacturing equipment to allow the Company to produce its cold brew products in house. This new lease should be finalized within the next 45 days.
L&P Cold Brew is looking to obtain part of the global ready to drink market share which, according to a report by Grand View Research, Inc. the global ready to drink tea and coffee market size is expected to reach 116.13 billion USD by 2024. US Sales alone in 2017 were over $38.1 million which is up over 460% from 2015
In closing, we have had another exceptional second quarter with revenue increase of over 17%. We are very excited about what we have accomplished thus far and are looking forward to an amazing second half of the year.
To follow the Company’s latest developments visit us on https://www.instagram.com/elev8hemp, on https://www.facebook.com/elev8hemp, and on https://twitter.com/elev8hemp.
Sincerely Yours,
Ryan Medico
Chief Executive Officer
THE QUICKEST WAY TO GET IN TROUBLE IS TELL THE TRUTH
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
